Work

Choosing the appropriate salvage therapy for B-cell non-Hodgkin lymphoma

Year: 2018

Type: editorial

Abstract: Salvage therapy for relapsed or refractory B-cell, non-Hodgkin lymphomas (NHL) depends on a number of factors including tumor histology, prior therapy, duration of prior response, patient age, como...

Source: Expert Opinion on Pharmacotherapy

DOI: 10.1080/14656566.2018.1518430

Authors: Hamza Hashmi, Mehdi Hamadani, Farrukh T. Awan

Institutions: University of Louisville, Medical College of Wisconsin, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2890282538

Cites: 25

Cited by: 3

Related to: 10